Global Bioenergies SA
PAR:ALGBE
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.4875
2.16
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ALGBE stock under the Base Case scenario is 0.897 EUR. Compared to the current market price of 0.827 EUR, Global Bioenergies SA is Undervalued by 8%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Global Bioenergies SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ALGBE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Global Bioenergies SA
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Global Bioenergies SA
Balance Sheet Decomposition
Global Bioenergies SA
Current Assets | 12.1m |
Cash & Short-Term Investments | 7.7m |
Receivables | 3.3m |
Other Current Assets | 1m |
Non-Current Assets | 1.6m |
Long-Term Investments | 347k |
PP&E | 1m |
Intangibles | 203.7k |
Current Liabilities | 4.1m |
Accounts Payable | 2.5m |
Accrued Liabilities | 213.2k |
Other Current Liabilities | 1.4m |
Non-Current Liabilities | 4.9m |
Long-Term Debt | 4.7m |
Other Non-Current Liabilities | 209.9k |
Earnings Waterfall
Global Bioenergies SA
Revenue
|
486.1k
EUR
|
Cost of Revenue
|
-6.3m
EUR
|
Gross Profit
|
-5.8m
EUR
|
Operating Expenses
|
-2.6m
EUR
|
Operating Income
|
-8.4m
EUR
|
Other Expenses
|
1.1m
EUR
|
Net Income
|
-7.4m
EUR
|
Free Cash Flow Analysis
Global Bioenergies SA
EUR | |
Free Cash Flow | EUR |
ALGBE Profitability Score
Profitability Due Diligence
Global Bioenergies SA's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
Global Bioenergies SA's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
ALGBE Solvency Score
Solvency Due Diligence
Global Bioenergies SA's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
Global Bioenergies SA's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ALGBE Price Targets Summary
Global Bioenergies SA
According to Wall Street analysts, the average 1-year price target for ALGBE is 3.366 EUR with a low forecast of 2.828 EUR and a high forecast of 3.99 EUR.
Dividends
Current shareholder yield for ALGBE is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ALGBE Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Global Bioenergies SA develops industrial processes to convert renewable sources into isobutene. The company is headquartered in Evry, Ile-De-France. The company went IPO on 2011-06-09. Isobutene, a hydrocarbon, can be converted into fuels such as isooctane, as well as into various materials (synthetic rubber, organic glass, plastics). The process developed by Global Bioenergies SA is based on the design of an artificial metabolic pathway comprising several enzymes catalyzing reactions not observed in nature. Six patent applications have been filed by the Company. The first two applications covering the key steps of the bio-production of isobutene and other olefins have already been published. The company distributes butane and propane containing bio-isobutene, in a e partnership with Global Bioenergies. The company operates through Syngip.
Contact
IPO
Employees
Officers
The intrinsic value of one ALGBE stock under the Base Case scenario is 0.897 EUR.
Compared to the current market price of 0.827 EUR, Global Bioenergies SA is Undervalued by 8%.